Papers

3

Total Citations

9

H-Index

2

About

Dr. Kyle Scarberry is a urologic surgeon and researcher whose work bridges oncologic surgery and gender-affirming care. His early research focused on prostate cancer outcomes, notably comparing robot-assisted and open radical prostatectomy in men with positive surgical margins—a study that has shaped discussions on surgical technique and biochemical recurrence. More recently, Dr. Scarberry has emerged as a pioneer in transgender surgery, particularly in revision vaginoplasty. His innovative use of decellularized fish skin xenografts (Kerecis™) for tissue-limited revision cases represents a novel approach to a challenging clinical problem. His 2024 work on this technique, presented at the Journal of Urology, and a subsequent 2026 paper detailing surgical outcomes, have garnered attention for expanding reconstructive options in gender-affirming surgery. With citations spanning from prostate oncology to transgender urology, Dr. Scarberry’s contributions reflect a commitment to advancing surgical techniques that improve both oncologic and quality-of-life outcomes for diverse patient populations.

Research Focus

Key Achievements

2
H-Index
3
Papers
9
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Comparison of Robot-Assisted and Open Retropubic Radical Prostatectomy for Risk of Biochemical Progression in Men with Positive Surgical Margins
6 citations · 2013
📈 Most Prolific Year: 2013 (1 Papers)
🤝 Key Collaborators: 19
🏛 Institutions: Columbia University Irving Medical Center, University Hospitals of Cleveland

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago